Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update
The PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial is 100% enrolled; expect to report topline data for this cohort in late Q1 2025 or Q2 ...
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
Cash and Cash Equivalents: As of September 30, 2024, Senti Bio held cash and cash equivalents of $10.5 million. Subsequent to quarter-end, the Company received $2.5 million, the second tranche of an ...
Le Lézard47m
Birchcliff Energy Ltd. Announces Q3 2024 Results, Declaration of Q4 2024 Dividend of $0.10 per Common Share and Preliminary 2025 Guidance
Birchcliff Energy Ltd. ("Birchcliff" or the "Corporation") is pleased to announce its Q3 2024 financial and operational results and its preliminary guidance for 2025. Birchcliff is also pleased to ...